Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9700583
Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
granted -
US 9700578
Use of nitrite salts for the treatment of cardiovascular conditions
granted -
US 9700562
Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis
granted -
US 9700529
Particulate materials
granted -
US 9700519
Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications
granted -
US 9700492
Dental composites systems and methods of making the same and using same
granted -
US 9695251
Activatable cell penetrating peptides with quenched fluorophores
granted -
US 9695246
Anti-OX40 antibodies and methods of using the same
granted -
US 9695229
Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules
granted -
US 9695230
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
granted -
US 9695223
Engineered xylose transporters with reduced glucose inhibition
granted -
US 9695249
Antibodies specific for urokinase-type plasminogen activator and methods of use thereof
granted -
US 9695150
Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof
granted -
US 9695153
Oligooxopiperazines for p53 reactivation
granted -
US 9695185
Synthetic methods for spiro-oxindole compounds
granted -
US 9694111
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
granted -
US 9694074
Functionalized porous silicon nanoparticles and use thereof in photodynamic therapy
granted -
US 9694071
Combination of anti-CD20 antibody and PI3 kinase selective inhibitor
granted -
US 9694062
Plasmodium falciparum sporozoite and liver stage antigens
granted -
US 9693998
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 9694077
Lipid compositions
granted -
US 9694047
Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)
granted -
US 9693999
Small molecule RNase inhibitors and methods of use
granted -
US 9694013
Therapeutically active compounds and their methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.